In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer (Q37403891)
Jump to navigation
Jump to search
scientific article published on 17 September 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer |
scientific article published on 17 September 2013 |
Statements
1 reference
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer (English)
1 reference
Frauke Bentzien
1 reference
Marcus Zuzow
1 reference
Nathan Heald
1 reference
Anna Gibson
1 reference
Yongchang Shi
1 reference
Leanne Goon
1 reference
Peiwen Yu
1 reference
Stefan Engst
1 reference
Wentao Zhang
1 reference
Donghui Huang
1 reference
Lora Zhao
1 reference
Valentina Vysotskaia
1 reference
Felix Chu
1 reference
Rajana Bautista
1 reference
Belinda Cancilla
1 reference
Peter Lamb
1 reference
Alison H Joly
1 reference
F Michael Yakes
1 reference
17 September 2013
1 reference
1 reference
1569-1577
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference